Since September 10 last year, newborns in Sweden have been offered an injection with antibodies against RS virus, and the initiative appears to have yielded results. So far in 2026, only one infant has been treated in intensive care due to RS infection. The treatment is offered to children born before or during the RS virus's high season, which is during the winter half-year, and provides protection for five to six months.
Data from the patient registry and the Swedish intensive care registry now show that the number of cases and hospital admissions since the treatment started in September last year is lower than in previous years. The number of children treated in intensive care has also decreased, with only one child so far. According to reports, it is highly likely that the antibody treatment has been decisive, though other factors such as a late RS season, mothers vaccinated during pregnancy not receiving treatment at birth, and the virus's alternating yearly activity may also influence comparisons.
fewer children needing intensive care reduces pressure on those departments, which is positive
Maria State reportedly said that fewer children needing intensive care reduces pressure on those departments, which is positive.